Effect of vegf gene knockdown on growth of the murine sarcoma cell line MS-K

Genes to Cells

Volumn 16, Issue 6, 2011, Pages 625-638

  Zhong, Xiu Y ^a,b   Yoshioka, Asami ^a   Mashio, Yuka ^a   Ikeda, Toru ^a   Jiang, Huijie ^b   Touma, Maki ^a   Wu, Qiong ^c   Wang, Changliu ^b   Sugimoto, Kenkichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b LUDONG UNIVERSITY   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOGENICITY; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; FEMALE; METASTASIS; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SARCOMA;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; MICE; MICE, INBRED C3H; NEOVASCULARIZATION, PATHOLOGIC; SARCOMA; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MURINAE; MUS;

EID: 79956319278     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2011.01513.x     Document Type: Article

References (30)

1. Aaronson, S.A. & Todaro, G.J. (1968) Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J. Cell. Physiol. 72, 141-148.
2. Das, B., Yeger, H., Tsuchida, R., Torkin, R., Gee, M.F., Thorner, P.S., Shibuya, M., Malkin, D. & Baruchel, S. (2005) A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res. 65, 7267-7275.
3. DeMorrow, S. (2009) Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation. Dig. Liver Dis. 41, 164-165.
4. Ellis, L.M. & Hicklin, D.J. (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8, 579-591.
5. Ferrara, N., Gerber, H.P. & LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
6. Graells, J., Vinyals, A., Figueras, A., Llorens, A., Moreno, A., Marcoval, J., Gonzalez, F.J. & Fabra, A. (2004) Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. J. Invest. Dermatol. 123, 1151-1161.
7. He, X.W., Yu, X., Liu, T., Yu, S.Y. & Chen, D.J. (2008) Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice. Chin. Med. J. (Engl) 121, 439-444.
8. He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., Harding, T., Jooss, K., Takahashi, T. & Alitalo, K. (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65, 4739-4746.
9. Helotera, H. & Alitalo, K. (2007) The VEGF family, the inside story. Cell 130, 591-592.
10. Itoh, K., Tezuka, H., Sakoda, H., Konno, M., Nagata, K., Uchiyama, T., Uchino, H. & Mori, K.J. (1989) Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp. Hematol. 17, 145-153.
11. Karamysheva, A.F. (2008) Mechanisms of angiogenesis. Biochemistry (Mosc) 73, 751-762.
12. Leblanc, G.G., Golanov, E., Awad, I.A. & Young, W.L. (2009) Biology of vascular malformations of the brain. Stroke 40, e694-e702.
13. Lee, T.H., Seng, S., Sekine, M., Hinton, C., Fu, Y., Avraham, H.K. & Avraham, S. (2007) Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med. 4, e186.
14. Lohela, M., Bry, M., Tammela, T. & Alitalo, K. (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 21, 154-165.
15. Mentlein, R., Forstreuter, F., Mehdorn, H.M. & Held-Feindt, J. (2004) Functional significance of vascular endothelial growth factor receptor expression on human glioma cells. J. Neurooncol. 67, 9-18.
16. Nishi, J., Minamino, T., Miyauchi, H., Nojima, A., Tateno, K., Okada, S., Orimo, M., Moriya, J., Fong, G.H., Sunagawa, K., Shibuya, M. & Komuro, I. (2008) Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt. Circ. Res. 103, 261-268.
17. Rangasamy, D., Tremethick, D.J. & Greaves, I.K. (2008) Gene knockdown by ecdysone-based inducible RNAi in stable mammalian cell lines. Nat. Protoc. 3, 79-88.
18. Raskopf, E., Vogt, A., Sauerbruch, T. & Schmitz, V. (2008) siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. J. Hepatol. 49, 977-984.
19. Reinacher-Schick, A., Pohl, M. & Schmiegel, W. (2008) Drug insight: antiangiogenic therapies for gastrointestinal cancers - focus on monoclonal antibodies. Nat. Clin. Pract. Gastroenterol. Hepatol. 5, 250-267.
20. Roskoski, R. Jr (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit. Rev. Oncol. Hematol. 62, 179-213.
21. Sher, I., Adham, S.A., Petrik, J. & Coomber, B.L. (2009) Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis. Int. J. Cancer 124, 553-561.
22. Shibata, M.A., Morimoto, J., Shibata, E. & Otsuki, Y. (2008) Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther. 15, 776-786.
23. Shibuya, M. (2008) Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep. 41, 278-286.
24. Shirata, K., Suzuki, T., Yanaihara, N., Sugimoto, K. & Mori, K.J. (1991) Establishment of a sarcoma cell line, MS-K, expressing Ki-ras proto-oncogene product from mouse bone marrow stromal cells. Biomed. Pharmacother. 45, 1-8.
25. Suzuki, J., Fujita, J., Taniguchi, S., Sugimoto, K. & Mori, K.J. (1992) Characterization of murine hemopoietic-supportive (MS-1 and MS-5) and non-supportive (MS-K) cell lines. Leukemia 6, 452-458.
26. Toda, K., Tsujioka, K., Maruguchi, Y., Ishii, K., Miyachi, Y., Kuribayashi, K. & Imamura, S. (1990) Establishment and characterization of a tumorigenic murine vascular endothelial cell line (F-2). Cancer Res. 50, 5526-5530.
27. Wang, J., Shi, Y.Q., Yi, J., Ye, S., Wang, L.M., Xu, Y.P., He, M. & Kong, X.M. (2008a) Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. J. Dig. Dis. 9, 228-237.
28. Wang, S., Liu, H., Ren, L., Pan, Y. & Zhang, Y. (2008b) Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia 10, 399-407.
29. Wartenberg, M., Gunther, J., Hescheler, J. & Sauer, H. (1998) The embryoid body as a novel in vitro assay system for antiangiogenic agents. Lab. Invest. 78, 1301-1314.
30. Weigand, M., Hantel, P., Kreienberg, R. & Waltenberger, J. (2005) Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis 8, 197-204.